PRACTICAL METHOD OF ADAPTIVE RADIOTHERAPY FOR PROSTATE CANCER USING REAL-TIME ELECTROMAGNETIC TRACKING

被引:23
作者
Olsen, Jeffrey R. [1 ]
Noel, Camille E. [1 ]
Baker, Kenneth [1 ]
Santanam, Lakshmi [1 ]
Michalski, Jeff M. [1 ]
Parikh, Parag J. [1 ]
机构
[1] Washington Univ, Dept Radiat Oncol, Sch Med, St Louis, MO 63110 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 82卷 / 05期
关键词
Prostate; Cancer; Radiotherapy; Intrafraction; Adaptive; BEAM RADIATION-THERAPY; DOSE-ESCALATION; INTRAFRACTION MOTION; LOCALIZATION; SYSTEM; TRIAL; CONSEQUENCES; GY;
D O I
10.1016/j.ijrobp.2011.01.040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We have created an automated process using real-time tracking data to evaluate the adequacy of planning target volume (PTV) margins in prostate cancer, allowing a process of adaptive radiotherapy with minimal physician workload. We present an analysis of PTV adequacy and a proposed adaptive process. Methods and Materials: Tracking data were analyzed for 15 patients who underwent step-and-shoot multi-leaf collimation (SMLC) intensity-modulated radiation therapy (IMRT) with uniform 5-mm PTV margins for prostate cancer using the Calypso (R) Localization System. Additional plans were generated with 0- and 3-mm margins. A custom software application using the planned dose distribution and structure location from computed tomography (CT) simulation was developed to evaluate the dosimetric impact to the target due to motion. The dose delivered to the prostate was calculated for the initial three, five, and 10 fractions, and for the entire treatment. Treatment was accepted as adequate if the minimum delivered prostate dose (D-min) was at least 98% of the planned D-min. Results: For 0-, 3-, and 5-mm PTV margins, adequate treatment was obtained in 3 of 15, 12 of 15, and 15 of 15 patients, and the delivered D-min ranged from 78% to 99%, 96% to 100%, and 99% to 100% of the planned D-min. Changes in D-min did not correlate with magnitude of prostate motion. Treatment adequacy during the first 10 fractions predicted sufficient dose delivery for the entire treatment for all patients and margins. Conclusions: Our adaptive process successfully used real-time tracking data to predict the need for PTV modifications, without the added burden of physician contouring and image analysis. Our methods are applicable to other uses of real-time tracking, including hypofractionated treatment. (c) 2012 Elsevier Inc.
引用
收藏
页码:1903 / 1911
页数:9
相关论文
共 27 条
[1]   Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers [J].
Aubry, JF ;
Beaulieu, L ;
Girouard, LM ;
Aubin, S ;
Tremblay, D ;
Laverdière, J ;
Vigneault, E .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01) :30-39
[2]   70 gy versus (vs) 80 gy dose escalation Getug 06 French trial for localized prostate cancer: Mature results [J].
Beckendorf, V. ;
Guerif, S. ;
Le Prise, E. ;
Cosset, J. ;
Bougnoux, A. ;
Chauvet, B. ;
Salem, N. ;
Romestaing, P. ;
Luporsi, E. ;
Bey, P. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01) :S96-S97
[3]  
Britton Keith R, 2005, Radiat Med, V23, P14
[4]   Intensity-modulated radiotherapy using implanted fiducial markers with daily portal imaging: Assessment of prostate organ motion [J].
Chen, Jergin ;
Lee, R. Jeffrey ;
Handrahan, Diana ;
Sause, William T. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03) :912-919
[5]   A treatment planning investigation into the dosimetric effects of systematic prostate patient rotational set-up errors [J].
Cranmer-Sargison, Gavin .
MEDICAL DOSIMETRY, 2008, 33 (03) :199-205
[6]   Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Fondurulia, J ;
Chen, MH ;
Kaplan, I ;
Beard, CJ ;
Tomaszewski, JE ;
Renshaw, AA ;
Wein, A ;
Coleman, CN .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :168-172
[7]   Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial [J].
Dearnaley, David P. ;
Sydes, Matthew R. ;
Graham, John D. ;
Aird, Edwin G. ;
Bottomley, David ;
Cowan, Richard A. ;
Huddart, Robert A. ;
Jose, Chakiath C. ;
Matthews, John H. L. ;
Millar, Jeremy ;
Moore, A. Rollo ;
Morgan, Rachel C. ;
Russell, J. Martin ;
Scrase, Christopher D. ;
Stephens, Richard J. ;
Syndikus, Isabel ;
Parmar, Mahesh K. B. .
LANCET ONCOLOGY, 2007, 8 (06) :475-487
[8]   A real-time MRI guided external beam radiotherapy delivery system [J].
Dempsey, J. ;
Dionne, B. ;
Fitzsimmons, J. ;
Haghigat, A. ;
Li, J. ;
Low, D. ;
Mutic, S. ;
Palta, J. ;
Romeijn, H. ;
Sjoden, G. .
MEDICAL PHYSICS, 2006, 33 (06) :2254-2254
[9]  
Deurloo KEI, 2005, INT J RADIAT ONCOL, V61, P1609
[10]   Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy [J].
Deurloo, KEI ;
Steenbakkers, RJHM ;
Zijp, LJ ;
de Bois, JA ;
Nowak, PJCM ;
Rasch, CRN ;
van Herk, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (01) :228-238